226 related articles for article (PubMed ID: 33423577)
1. A High-Throughput RNA Displacement Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex toward Developing Therapeutics for COVID-19.
Perveen S; Khalili Yazdi A; Devkota K; Li F; Ghiabi P; Hajian T; Loppnau P; Bolotokova A; Vedadi M
SLAS Discov; 2021 Jun; 26(5):620-627. PubMed ID: 33423577
[TBL] [Abstract][Full Text] [Related]
2. A High-Throughput Radioactivity-Based Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex.
Khalili Yazdi A; Li F; Devkota K; Perveen S; Ghiabi P; Hajian T; Bolotokova A; Vedadi M
SLAS Discov; 2021 Jul; 26(6):757-765. PubMed ID: 33874769
[TBL] [Abstract][Full Text] [Related]
3. Binding of the Methyl Donor
Aouadi W; Blanjoie A; Vasseur JJ; Debart F; Canard B; Decroly E
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031370
[TBL] [Abstract][Full Text] [Related]
4. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp14 RNA cap methyltransferase.
Basu S; Mak T; Ulferts R; Wu M; Deegan T; Fujisawa R; Tan KW; Lim CT; Basier C; Canal B; Curran JF; Drury LS; McClure AW; Roberts EL; Weissmann F; Zeisner TU; Beale R; Cowling VH; Howell M; Labib K; Diffley JFX
Biochem J; 2021 Jul; 478(13):2481-2497. PubMed ID: 34198328
[TBL] [Abstract][Full Text] [Related]
5. Molecular Simulation-Based Investigation of Highly Potent Natural Products to Abrogate Formation of the nsp10-nsp16 Complex of SARS-CoV-2.
Mohammad A; Alshawaf E; Marafie SK; Abu-Farha M; Al-Mulla F; Abubaker J
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33919870
[TBL] [Abstract][Full Text] [Related]
6. Development of a High-Throughput Screening Assay to Identify Inhibitors of the SARS-CoV-2 Guanine-N7-Methyltransferase Using RapidFire Mass Spectrometry.
Pearson LA; Green CJ; Lin D; Petit AP; Gray DW; Cowling VH; Fordyce EAF
SLAS Discov; 2021 Jul; 26(6):749-756. PubMed ID: 33724070
[TBL] [Abstract][Full Text] [Related]
7. Localization of SARS-CoV-2 Capping Enzymes Revealed by an Antibody against the nsp10 Subunit.
Horova V; Landova B; Hodek J; Chalupsky K; Krafcikova P; Chalupska D; Duchoslav V; Weber J; Boura E; Klima M
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452352
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex.
Chen Y; Su C; Ke M; Jin X; Xu L; Zhang Z; Wu A; Sun Y; Yang Z; Tien P; Ahola T; Liang Y; Liu X; Guo D
PLoS Pathog; 2011 Oct; 7(10):e1002294. PubMed ID: 22022266
[TBL] [Abstract][Full Text] [Related]
9. Substrate Specificity of SARS-CoV-2 Nsp10-Nsp16 Methyltransferase.
Benoni R; Krafcikova P; Baranowski MR; Kowalska J; Boura E; Cahová H
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578302
[TBL] [Abstract][Full Text] [Related]
10. Mn
Minasov G; Rosas-Lemus M; Shuvalova L; Inniss NL; Brunzelle JS; Daczkowski CM; Hoover P; Mesecar AD; Satchell KJF
Sci Signal; 2021 Jun; 14(689):. PubMed ID: 34131072
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of SARS-CoV-2 nsp10-nsp16 in complex with small molecule inhibitors, SS148 and WZ16.
Klima M; Khalili Yazdi A; Li F; Chau I; Hajian T; Bolotokova A; Kaniskan HÜ; Han Y; Wang K; Li D; Luo M; Jin J; Boura E; Vedadi M
Protein Sci; 2022 Sep; 31(9):e4395. PubMed ID: 36040262
[TBL] [Abstract][Full Text] [Related]
12. A universal fluorescence polarization high throughput screening assay to target the SAM-binding sites of SARS-CoV-2 and other viral methyltransferases.
Samrat SK; Bashir Q; Zhang R; Huang Y; Liu Y; Wu X; Brown T; Wang W; Zheng YG; Zhang QY; Chen Y; Li Z; Li H
Emerg Microbes Infect; 2023 Dec; 12(1):2204164. PubMed ID: 37060263
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure and functional analysis of the SARS-coronavirus RNA cap 2'-O-methyltransferase nsp10/nsp16 complex.
Decroly E; Debarnot C; Ferron F; Bouvet M; Coutard B; Imbert I; Gluais L; Papageorgiou N; Sharff A; Bricogne G; Ortiz-Lombardia M; Lescar J; Canard B
PLoS Pathog; 2011 May; 7(5):e1002059. PubMed ID: 21637813
[TBL] [Abstract][Full Text] [Related]
14. Virtual screening, ADME/T, and binding free energy analysis of anti-viral, anti-protease, and anti-infectious compounds against NSP10/NSP16 methyltransferase and main protease of SARS CoV-2.
Maurya SK; Maurya AK; Mishra N; Siddique HR
J Recept Signal Transduct Res; 2020 Dec; 40(6):605-612. PubMed ID: 32476594
[TBL] [Abstract][Full Text] [Related]
15. High-resolution structures of the SARS-CoV-2 2'-
Rosas-Lemus M; Minasov G; Shuvalova L; Inniss NL; Kiryukhina O; Brunzelle J; Satchell KJF
Sci Signal; 2020 Sep; 13(651):. PubMed ID: 32994211
[TBL] [Abstract][Full Text] [Related]
16. Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin.
Krafcikova P; Silhan J; Nencka R; Boura E
Nat Commun; 2020 Jul; 11(1):3717. PubMed ID: 32709887
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the SARS-CoV-2 ExoN (nsp14ExoN-nsp10) complex: implications for its role in viral genome stability and inhibitor identification.
Baddock HT; Brolih S; Yosaatmadja Y; Ratnaweera M; Bielinski M; Swift LP; Cruz-Migoni A; Fan H; Keown JR; Walker AP; Morris GM; Grimes JM; Fodor E; Schofield CJ; Gileadi O; McHugh PJ
Nucleic Acids Res; 2022 Feb; 50(3):1484-1500. PubMed ID: 35037045
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of RNA cap modification by SARS-CoV-2.
Viswanathan T; Arya S; Chan SH; Qi S; Dai N; Misra A; Park JG; Oladunni F; Kovalskyy D; Hromas RA; Martinez-Sobrido L; Gupta YK
Nat Commun; 2020 Jul; 11(1):3718. PubMed ID: 32709886
[TBL] [Abstract][Full Text] [Related]
19. Label-Free Screening of SARS-CoV-2 NSP14 Exonuclease Activity Using SAMDI Mass Spectrometry.
Scholle MD; Liu C; Deval J; Gurard-Levin ZA
SLAS Discov; 2021 Jul; 26(6):766-774. PubMed ID: 33870746
[TBL] [Abstract][Full Text] [Related]
20. Exploring the Catalytic Mechanism of the RNA Cap Modification by nsp16-nsp10 Complex of SARS-CoV-2 through a QM/MM Approach.
Silva JRA; Urban J; Araújo E; Lameira J; Moliner V; Alves CN
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
